BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26338801)

  • 21. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
    Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
    Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation.
    Hayes JL; Tzika A; Thygesen H; Berri S; Wood HM; Hewitt S; Pendlebury M; Coates A; Willoughby L; Watson CM; Rabbitts P; Roberts P; Taylor GR
    Genomics; 2013 Sep; 102(3):174-81. PubMed ID: 23598253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative genomic hybridization for analysis of changes in DNA copy number in multiple myeloma.
    Rao PH
    Methods Mol Med; 2005; 113():71-83. PubMed ID: 15968096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The comparison of three cytogenetic methods for detecting multiple myeloma].
    Ren J; Yang LH; Li GX; Fan JL; Hou J
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):737-40. PubMed ID: 20079209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic tools for risk-stratification in multiple myeloma].
    Braggio E; Albarracín Garramuño F
    Medicina (B Aires); 2013; 73(4):369-75. PubMed ID: 23924539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative genomic hybridization based strategy for the analysis of different chromosome imbalances detected in conventional cytogenetic diagnostics.
    Tönnies H; Stumm M; Wegner RD; Chudoba I; Kalscheuer V; Neitzel H
    Cytogenet Cell Genet; 2001; 93(3-4):188-94. PubMed ID: 11528111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultra-low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma.
    Buedts L; Smits S; Ameye G; Lehnert S; Ding J; Delforge M; Vermeesch J; Boeckx N; Tousseyn T; Michaux L; Vandenberghe P; Dewaele B
    Genes Chromosomes Cancer; 2020 Aug; 59(8):465-471. PubMed ID: 32259320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma].
    Gao L; Liu Q; Shi Y; Dang H; He Q; Wang Z; Feng L; Li Y; Wang XY; Li N; Song WJ; Wang YL; Kong S; Lu J; Huang XJ; Lai YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):807-812. PubMed ID: 28641640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load.
    Neben K; Jauch A; Hielscher T; Hillengass J; Lehners N; Seckinger A; Granzow M; Raab MS; Ho AD; Goldschmidt H; Hose D
    J Clin Oncol; 2013 Dec; 31(34):4325-32. PubMed ID: 24145347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
    Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
    Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical applications of array CGH and the transformation of clinical cytogenetics.
    Shaffer LG; Bejjani BA
    Cytogenet Genome Res; 2006; 115(3-4):303-9. PubMed ID: 17124414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytogenetic Abnormalities and Outcomes of 117 Patients with Multiple Myeloma Detected by FISH].
    Zhai B; Zou DD; Yan JJ; Wang N; Wang LL; Zhu HL; Huang WR; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):127-30. PubMed ID: 26913408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytogenetic study on 53 patients with multiple myeloma].
    Jing Y; Fang MY; Jiang F; Lin S; Wang FT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):68-72. PubMed ID: 21362224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH).
    Schoumans J; Ruivenkamp C; Holmberg E; Kyllerman M; Anderlid BM; Nordenskjöld M
    J Med Genet; 2005 Sep; 42(9):699-705. PubMed ID: 16141005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of cytogenetic aberrations of multiple myeloma].
    Wang XW; Li JY; Chen LJ; Qian SX; Hong M; Qiao C; Zhang JF; Xu W; Lu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1316-9. PubMed ID: 19099635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
    Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
    Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High detection rate of clinically relevant genomic abnormalities in plasma cells enriched from patients with multiple myeloma.
    Stevens-Kroef M; Weghuis DO; Croockewit S; Derksen L; Hooijer J; Elidrissi-Zaynoun N; Siepman A; Simons A; Kessel AG
    Genes Chromosomes Cancer; 2012 Nov; 51(11):997-1006. PubMed ID: 22833442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.